leadf
logo-loader
viewScancell Holdings PLC

Scancell Holdings awarded funds from Innovate UK for COVID-19 vaccine

Scancell Holdings' (LON:SCLP) Dr Cliff Holloway talks to Proactive London's Katie Pilbeam after being awarded funds from Innovate UK to produce a COVID-19 vaccine.

Holloway explains how the company is using their immunotherapies knowledge which is used in their cancer research projects to help with the COVID-19 drive.

Alongside this the company's lead drug, SCIB-1 to treat skin cancer has recently entered a phase II clinical trial in the UK.

Quick facts: Scancell Holdings PLC

Price: 13.5 GBX

LSE:SCLP
Market: LSE
Market Cap: £99.71 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Scancell Holdings PLC named herein, including the promotion by the Company of Scancell Holdings PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: UK awaits Westminsters' three-tier local lockdown system

FTSE 100 opened lower as it nervously awaits Westminster’s announcement on the three-tier local lockdown system scheduled for today. British Airways is replacing chief executive Alex Cruz with Aer Lingus boss Sean Doyle. Cruz was criticised by politicians and trade unions after cutting 10,700...

2 weeks, 4 days ago

2 min read